Table 1 Baseline characteristics
Characteristics | Intervention (n = 15) | Control (n = 15) | P-value* | |
|---|---|---|---|---|
GA at birth, mean (SD), [weeks + days] | 23 + 6 (0 + 5) | 24 + 4 (0 + 6) | 0.06 | |
Weight at birth, mean (SD), [g] | 650 (115) | 615 (95) | 0.38 | |
Antenatal steroids (complete administration), n (%) | 9 (60) | 8 (53) | 0.79 | |
Male, n (%) | 9 (60) | 10 (67) | 0.45 | |
Day of life at HFOV start, mean (SD), [d] | 3 (4) | 5 (6) | 0.23 | |
GA at HFOV start, mean (SD), [weeks + days] | 24 + 2 (0 + 6) | 25 + 1 (1 + 1) | 0.03 | |
Weight at HFOV start, mean (SD), [g] | 650 (115) | 615 (105) | 0.36 | |
OSI at HFOV start, mean (SD) | 4.09 (1.94) | 5.87 (3.64) | 0.11 | |
Main cause of respiratory failure | ||||
Severe respiratory distress syndrome, n (%) | 11 (73.3) | 7 (46.7) | 0.26 | |
Sepsis, n (%) | 1 (6.7) | 4 (26.7) | 0.33 | |
Pneumonia, n (%) | 0 (0) | 2 (13.3) | 0.48 | |
Necrotizing enterocolitis, n (%) | 2 (13.3) | 1 (6.7) | 1.0 | |
Severe pulmonary hypertension, n (%) | 1 (6.7) | 1 (6.7) | 1.0 | |